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Underlying all immune responses are the developmental programs that give immune cells
their identities. Developmental controls determine the kinds of effector mechanisms that are
available to different classes of cells, the degree of amplification that they can achieve
through clonal expansion, the signals that they will respond to, and the limits that will be set
on their abilities to alter function in different environmental conditions. As all these cell
types are ultimately derived from common hematopoietic precursors, they each become
distinct from other cell types at developmental choice points that define a time course of
branching lineage relationships. This volume showcases striking new advances that
illuminate the mechanisms governing several particularly interesting choice points where
divergent immune cell identities are established.
Recent perspectives on immune cell modes of development
Development in the immune system raises a number of issues that are not usually addressed
in classic embryonic developmental systems. One is the mobility of the cells, both in their
functional roles and in their traffic to diverse inductive microenvironments, which
introduces a stochastic element. Another is the question of when the irreversible aspects of
immune-cell differentiation end and physiologically reversible ‘effector responses’ begin.
The cells that mediate both adaptive and innate branches of immunity are specialized for the
ability to mobilize finely tuned response programs based on the combinations of signals that
they detect in the environment. This responsiveness involves major inducible changes in
gene expression as well as effects on migration, morphology, and proliferation or death. All
mature immune cells have sophisticated machinery for powerful signal-dependent
responses. The behavior of a mature immune cell in a given situation can be seen as the
superimposition of an environmentally modulated gene expression program on top of the
core gene expression program dictated by that cell's developmental history. But what
determines the stability of the core program?
How this actually works is turning out to be more interesting, and more complex, than might
have been suspected earlier, as described by the reviews in this volume. There is an
increasing appreciation of the highly branched nature of immune cell developmental
pathways. The best known cases are the divergence of different T-cell receptor (TCR) αβ T-
cell subtypes during intrathymic positive selection, and the multiple T-helper (Th) subsets of
conventional CD4+ TCRαβ+ T cells generated during responses to antigen. But
multibranched pathways are now also recognized for TCRγδ+ cells, unconventional T cells,
NK cells, and dendritic cells. It remains an active question how firm is the boundary
between a ‘lineage decision’ and an ‘activation state’ in these branch points. Effector subsets
of CD4+ T cells, such as Th1 and Th2 cells, were originally thought to be irreversibly
polarized, terminal fates; however, as additional subsets have been defined, evidence has
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also accumulated for plasticity and for the potential for interconversion among these effector
fates.
Whereas different variants of T, NK, and dendritic cells are increasingly recognized as
distinct, other branches of immune cell development appear now to be less clearly separated.
It was thought for many years that the precursors of innate immune cells and the precursors
of all adaptive immune cells were completely separate, having diverged much earlier in the
hematopoietic hierarchy. This might suggest that once the initial lympho/myeloid decision
was made, completely different sets of regulatory molecules could program the choices
made at lower levels of the hierarchy. However, it is now clear that myeloid and lymphoid
development can be closely intertwined, as discussed from several points of view in
contributions in this volume (1-6). Not only can lymphoid and myeloid cells be derived from
overlapping precursor subsets (under appropriate conditions) but also for developmental
decisions, they can share use of the same lineage-defining transcription factors. These
shared regulatory molecules participate in different combinations of factors to promote
distinct cell fate choices across the adaptive/innate divide, such as PU.1 in dendritic cells
and B cells, or Id2 and PLZF (Zbtb16) in NK cells, myeloid cells, iNKT cells, and some
TCRγδ cells (4,7-10). It is the combination that specifically defines an ‘adaptive’ or ‘innate’
immune cell program, rather than any ‘master gene’ itself, and access to a cell fate can
probably be restricted by control over any member of the combination.
Organization and scope of this issue
This volume highlights a number of key branchpoints in the lympho-hematopoietic
developmental decision tree, where new evidence illuminates the molecules that exert
control. T-lineage examples are prominent, as T-cell development has long been recognized
to include multiple tiers of fate choices. Here these choices are discussed in the context of
mechanisms used for B-cell, NK cell, dendritic cell, and progenitor cell fate determination
as well. The reviews here cover lymphoid/myeloid lineage choice among hematopoietic
precursors, B-cell developmental checkpoints, both in normal cells and as they are distorted
in malignancy, specification of dendritic cells and divergence among dendritic cell subsets.
A series of reviews then consider molecules that act at a succession of branchpoints along
the T-cell developmental pathway: mechanisms separating T/NK precursors from myeloid
cells, T from NK cells, αβ T cells from γδ T cells and different γδ T cell subsets from one
another, mechanisms creating divergences between conventional TCRαβ+ T cells and
‘innate-like’ iNKT cells, and finally mechanisms specifying and maintaining distinctions
among different mature effector T-cell subsets. Focusing on the most mature and best-
defined cell types, contributors describe in detail the biochemical mechanisms of action of
the controlling transcription factors themselves and the how they work on cis-regulatory
elements of the key target genes in the differentiation pathways. These are models of the
level of understanding that it is hoped the earlier, more complex developmental choices will
eventually receive.
An area that is unfortunately underrepresented in this collection is the diversification and
terminal maturation of B cells, which involves an important developmental switch that is
based on the balance between two sets of mutually antagonistic regulators. However, the
relationships between ‘adaptive immune’ lymphoid programs for B and T cells and the
‘innate immune’ differentiation programs used in dendritic cells, natural killer cells,
monocytes, and granulocytes are a recurrent theme. Contributions in this volume address
these relationships both at the cell biological level and in terms of the roles of factors like
PU.1, E proteins, STAT factors, GATA-3, PLZF, Notch, ThPOK, T-bet, and the newly
appreciated factor Bcl11b, as summarized below.
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Early lymphoid precursors and the question of prior restriction
B cells and T cells share undisputed central roles in adaptive immunity, also sharing many
similar features of cell biology and the unique use of recombination-activating gene (RAG)-
mediated recombination to distinguish them from all other cell types, including even their
lymphoid relatives the NK cells. The discovery of common lymphoid precursors marked by
interleukin-7 receptor (IL-7R) expression (11) was a watershed for the field, as the first
prospective isolation of individual progenitors with defined partial restrictions on potential,
but it was also deeply appealing as evidence that the similarities between T and B cells
might result from a uniquely shared inheritance. However, problems have arisen with the
notion that B and T cells emerge from a precursor that first loses all nonlymphoid potentials
before choosing between T and B fates.
These problems have commanded most attention with respect to the T-cell pathway, where
isolation of an ordered succession of precursors from the thymus is fairly easy, and many
independent labs have observed what these cells do when tested in different environmental
conditions (reviewed here in 2, 3). It is seen here that B-cell potential is completely
extinguished soon after the precursors enter the thymus, and yet a robust myeloid potential
continues to be preserved for multiple cell divisions into T-cell specification. This myeloid
potential is conditional, as it is restricted by environmental signals in the thymus, but it is
quite evident upon transfer of the cells to permissive conditions in vitro, so that the later
stage when myeloid potential is also lost can be clearly defined. There is also molecular
evidence to explain how the normal gene regulatory features of early T-cell precursors in the
thymus would still give access to myeloid but not B-cell programs. These T-lineage
precursor assays thus imply that T and B-cell potential segregate before T-cell precursors
lose myeloid or NK potential. However, evidence both old and new has been adduced to
show that in vivo, under unperturbed conditions, the cells that seed the thymus may very
well have a history of IL-7R expression, resembling the common lymphoid precursors. Even
though these cells can undergo myeloid differentiation in vitro, they are poorer at generating
myeloid cells in vivo than stem cells or dedicated myeloid precursors (12,13), and the
meaning of this discrepancy has been sharply debated.
The authors in this volume address this problem from several points of view. Yang et al. (2)
review the observed sequence of lineage commitment stages for T-cell precursors,
combining discussion of underlying transcriptional requirements with an emphasis on the
environmental dependence of all these fate decisions. Thus, T-lineage competence depends
first of all on the ability of the candidate precursors to enter the thymus, where the all-
important Delta-like 4 Notch ligand drives the inductive signaling that triggers and sustains
the T-cell program. These authors point to the crucial importance of chemokine receptor
regulation in controlling this process, thus determining the range of inductive signals a cell
would ever actually see in vivo. Kawamoto et al. (3) focus on mechanisms that sustain and
limit intrinsic myeloid competence, relating these to a broader hematopoietic context. They
argue that a conditional myeloid potential may be a basic feature of hematopoiesis, a latent
but useful program option with deep evolutionary roots that can be given up only when T, B,
or erythroid cells become fully committed to another fate. Kondo (1) reviews the early
lymphoid precursor debate from a vantage point based on B and myeloid-development,
which both develop in the bone marrow. Here again, there is a conflict between the range of
potentials that ‘lymphoid precursors’ show in vivo and in vitro. Kondo notes that in fact the
bone marrow microenvironment is quite diversified and that regulated migration into
particular zones within it is crucial for cells to receive appropriate signals for the lymphoid
and myeloid programs. He cites results that inhibition of the appropriate chemokine receptor
signals may be sufficient to reveal the latent myeloid potential in lymphoid precursors. Thus,
even if lymphoid precursors express myeloid transcription factors, a strong bias for
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lymphoid lineage restriction may arise by programming cells to migrate in vivo to sites
where lymphoid but not myeloid development is supported. Thus, the range of competence
of the cells in vivo is partly a result of intrinsic regulatory state but also partly a result of the
cells' ability to choose their own homing sites, where cell non-autonomous mechanisms then
come forcefully into play.
Lessons from B-cell and dendritic cell development
B-cell developmental paradigms have led the field for over a decade (14-17). B cells depend
for their specification on a small group of transcription factors, two of which, EBF1 and
Pax5, are B-lineage specific, so that hematopoietic precursors lacking these factors show
selective B-cell defects. It was through analysis of these factors' effects that the distinction
first emerged clearly between positive regulation of lineage-specific genes (‘specification’)
and exclusion of alternative fates (‘commitment’)(18). More widely shared factors like the
E-protein E2A gain B-cell specific roles through incorporation in a network organized
around the core of these two highly specific factors (19-21), as reviewed here by Zandi et al.
(6). EBF1 and Pax5 and the expression of B-cell target genes in precursors are among the
earliest signs of competence to generate B-cell progeny. Zandi et al. describe how lineage
priming, i.e. initial onset of B-cell gene expression, substantially precedes commitment, and
then the separate mechanisms through which actual B-lineage commitment is established.
One crucial regulator used in B-cell development is shared with myeloid cells, namely PU.1.
This Ets-family transcription factor works not only to promote myeloid and dendritic cell
development but also to set up a pool of competent precursors for lymphoid development,
and much later, to regulate aspects of B-cell responses to antigen (4). Carotta et al. now
review these innate and adaptive functions, highlighting a dose-dependent role for PU.1 in
dendritic cell development that is explained in part by exquisitely sensitive PU.1 regulation
of the Flt3 (Flk2) cytokine receptor gene.
Dendritic cells are highly diverse and programmed through distinctive, signal-dependent
pathways. Watowich and Liu (22) reveal the web of mechanisms through which instructive
signaling from cytokine and Toll-like receptors blends with cell-intrinsic transcription factor
activities to direct dendritic cell subtype programs. In this complex network, there is clear
evidence that distinct, cytokine-activated signal transducer and activator of transcription
(STAT) factors and interferon-response factors (IRFs) play individualized, instructive roles
both to foster certain fates and to block others. This recently appreciated network echoes
aspects of the complex STAT-dependent networks governing CD4+ T-cell effector fates,
described later in the volume.
Regulatory factors that define lymphocyte identity: early precursor, T, and
NK fates
PU.1 is perhaps the main transcription factor that all immune cells, adaptive and innate,
most distinctively share, for at least some parts of their developmental histories. In contrast,
the next sections of this volume focus on the factors whose activities cause the
discontinuities between one immune cell type and another.
If there were a ‘master regulator’ for the genes that distinguish B and T cells from innate
immune cells, E proteins would probably head the list of candidates. This family of
transcription factors, including E2A, HEB (Tcf12), and E2-2 (Tcf4), repeatedly contributes
to lymphoid developmental potential as well as to developmental subchoices and
checkpoints within lymphoid fates. As reviewed by De Pooter and Kee (8), these factors and
their intricately regulated inhibitors play roles in setting up precursors with lymphoid
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potential in the first place, blocking diversion to the myeloid mainstream, and again to
separate B and T cells from their innate relatives like NK cells and most dendritic cells.
However, constitutively activated effectors with hybrid innate/adaptive character, like iNKT
cells (invariant TCRα NK-like T cells), also appear to use E protein inhibitors for their final
maturation. De Pooter and Kee set the actions of E proteins in the context of the broader
networks of regulatory genes in B and T cells.
For T cells, an equally indispensable factor is GATA-3. Hosoya et al. (23) review the
complex activities of this factor, which is crucial for establishing the source pool of
progenitor cells within the thymus and is then used again and again throughout T-cell
development. Work from the authors' own laboratory as well as others illustrates the
extreme dose dependence of GATA-3 in T-cell development from early stages, where it can
act as a bridge between the T-cell fate and other fates for precursors, such as NK cells and
even mast cells. These features of GATA-3 function have made it a challenge to study, but
its vital role in T-cell development is now yielding to advanced transgenic and molecular
approaches (23).
For T-lineage precursors, the most closely related non-T fate is that of NK cells. Although
many NK cells develop without entering the thymus, there is substantial NK developmental
potential among early T-cell precursors and a distinctive set of NK cells that develops in the
thymus as well, and the regulatory inputs that determine these NK fates are reviewed by
Klein Wolterink et al. (9). It has been known for a decade that E protein antagonist Id2 is
important for NK cell maturation, but a number of other transcription factors besides
GATA-3 and Id2 are now clearly implicated in distinct aspects of NK cell development.
Recently, the T-cell transcription factor Bcl11b has been identified as a factor that sets the
boundary between ‘T-cell’ and ‘NK cell’ gene expression programs (24,25), as well as a
factor that controls a commitment checkpoint within the T-lineage itself (25,26). Originally
known to be required for correct regulation of later stages of T-cell development and
selection (27-31), this newly recognized early role makes Bcl11b interesting for its role in T-
lineage identity. Bcl11b features prominently in six articles in this collection (2,3,5,8,9,32).
The nature of this factor and the evidence for its role in NK development are reviewed in
detail by P. Liu et al. (32). The evidence they discuss implies that Bcl11b may provide the
single regulatory function that is crucial to distinguish the T-cell fate from the NK cell fate.
These authors also describe the remarkable functional properties of mature T cells that have
been converted to a partial NK-like status by deletion of Bcl11b in vivo. A model proposing
that T vs. NK lineage choice decisions may be based on the opposition of Bcl11b to Nfil3 is
presented by Klein Wolterink et al. (9).
The last of the reviews on early T-cell development, from the guest editor's group (5), draws
on regulatory gene expression profiling and analysis of Bcl11b-deficient mutants to argue
for a two-phase program in early T-cell development. A checkpoint boundary (see also 3) is
proposed to divide an initial, growth promoting phase, which is governed by a legacy of
stem-cell associated genes, from the later, post-commitment phase focused on TCR gene
rearrangement and selection, when the stem-cell associated genes are repressed. In this
model, the bridges from the T-cell program to alternative fates depend on the specific
regulatory state in the initial phase. Bcl11b is sharply induced in vivo just before the
boundary between the phases. It is required directly or indirectly to drive the loss of self-
renewal potential as well as to ‘gate’ the transition to commitment within the T-cell
development program (5).
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Regulation of distinct T-cell subtypes: divergent fates in the thymus
The transition to commitment is closely linked to the earliest point of bifurcation between at
least some of the T cells that can develop as TCRγδ cells and those that will develop as
TCRαβ cells. The αβ/γδ lineage divergence has become a focus of high attention in recent
years, as TCRγδ cells have been revealed to constitute a diverse cluster of cell types. TCRγδ
cells are distinct from each other in use of Notch signals, E proteins and their antagonists,
and other regulatory factors including ThPOK (cKrox, Zbtb7b), T-bet (Tbx21), and its
relative Eomesodermin, and Runx3, and also functionally distinct in their expression of the
effector cytokines IFNγ or IL-17, as reviewed here by Kreslavsky et al. (10). These authors
consider the mechanisms that separate TCRγδ differentiation pathways from TCRαβ
differentiation pathways as well as models for TCRγδ subset selection, some of which
appear to use highly biased selections of γ and δ gene segments in their TCR
rearrangements. Taking aim at the underlying problem of the nature of ‘the TCRγδ
program’, they challenge whether this is a single program with subordinate branches or
whether it is in fact a collection of distinct regulatory programs.
The next major intrathymic bifurcation is the separation between CD4+ and CD8+ TCRαβ
cells, as a result of positive selection. The discovery that ThPOK (cKrox, Zbtb7b) was a
dominant and indispensable regulator of the CD4+ cell fate was one of the major advances in
this field (33,34). As for many of the factors involved in T-cell development, however,
ThPOK is turning out to play a wider range of roles, and these are described in detail by
Kappes (35). In particular, ThPOK is important for generation of two of the most mature
subsets of TCRγδ cells and to regulate the cytokine expression repertoire of the mature
TCRγδ pool. ThPOK is also needed to confer or maintain some of the properties of iNKT
cells.
The iNKT fate itself is a seeming hybrid, with much of an innate-like cell type in its
response machinery in spite of its conventionally adaptive use of rearranging TCRαβ genes,
and its requirement for TCR ligand-dependent positive selection. There are different subsets
of these cells as well and an increasingly rich appreciation of the roles they can play in
immune responses. As reviewed by Das et al. (7), iNKT cells (and other innate-like T-cell
subsets) have a distinctive set of positive selection signaling requirements and a distinctive
requirement for the Zbtb factor PLZF (Zbtb16), as well as use of the E protein antagonist
Id2 for their terminal differentiation, which divide them from conventional T cells.
However, like conventional CD4+ T cells they are diverse in function and phenotype, and
Das et al. review the evidence that ‘innate-type’ TCRαβ cells exemplified by iNKT cells
may be sub-specialized comparably to conventional CD4+ T cells (7). Taking the work on
NK, TCRγδ, and iNKT cells together, diversity of TCR, type of TCR, functional
subspecialization, and even the use of a TCR at all are capable of being combined in
different ways at the adaptive/innate immune system interface.
Mechanisms of effector T-cell divergence in the periphery: gene network-
level lockdown and epigenetic plasticity
The last part of the volume delves into the sophisticated approaches that are now revealing
how particular transcription factors and particular transcription factor target genes actually
execute their roles in these effector fate decisions. Balasubramani et al. (36) focus on the
cis-acting molecular mechanisms involved in activating expression of the IFNγ and IL-17
genes, which distinguish not only Th1 and Th17 CD4+ conventional T cells but also subsets
of mature TCRγδ cells (35) and subsets of iNKT cells (7). Balasubramani et al. (36) identify
the far-spread regulatory sequences that are now recognized to contribute to the opening of
these loci and the transcription factors that act at each of these sites. They show how the
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accessibility of these cis-regulatory sites even in ‘terminally differentiated’ effector cells is
still open to modulation under the influence of certain cytokine signaling pathways. Turning
to another close view of Th1 cell specification, this time from the focal point of the trans-
acting transcription factor, Miller and Weinmann (37) take the killer T-cell, NK-cell, and
Th1-cell regulator T-bet (Tbx21) as a model for biochemical examination. They detail the
intricate combination of positive and negative regulatory effects of this single factor in terms
of the different particular chromatin remodeling factors that interact with it through distinct
protein-protein interaction domains, enabling T-bet to activate or repress specific targets.
This example illustrates much of what is likely to be happening at the protein level with
other transcription factors as well in order to bring about the chromatin changes discussed
by Balasubramani et al. (36).
These fine-scale analyses ultimately must connect into a broader picture of transcription
factor mobilization to define different CD4+ T-cell effector subtypes, and a model for this
larger network is comprehensively laid out at the end of this volume by Zhu and Paul (38).
The summary presented seeks to account not only for the channeling of effector cells into
Th1, Th2, Th17, regulatory T cell, T follicular helper, and Th9 ‘fates’ but also for the
cytokine-dependent plasticity that remains to enable a limited degree of interconversion in
particular circumstances, examples of which are noted in both of the previous reviews. This
gene network and its signaling-dependent inputs illustrates the reciprocal interactions
between the transcription factors within the cells and the cytokine signals that the cells do or
do not receive from their environments, in part depending on the regulated expression of
cytokine receptors and signal transduction genes (38). It is this iterative set of regulatory
relationships that shapes the effector response of mature TCRαβ T cells in the periphery.
Conclusions
The reviews in this volume address only a fraction of the immune cell lineage commitment
field, but they illustrate several central points. One is how the combination of particular
signals from the environment collaborates with a cell's current transcription factor regulatory
ensemble to promote development along a particular pathway or to exclude an alternative.
Another point is that in general, many immune cell development pathways are profoundly
branched and diversified even after major aspects of lineage commitment, at least including
dendritic cell, NK cell, or T-cell fates. These developmental pathways genuinely appear to
splay out toward distinct endpoints that are not simply more or less mature but in fact
different ‘mature’ states. Regulatory explanations for the boundaries between these subtypes
are rapidly emerging, and they appear to be mechanisms somewhat less rigid than the
lineage exclusion mechanisms separating major immune cell classes and the mechanisms
conferring transient response functions. However, ‘diversification factors’ like E proteins
and their antagonists, PLZF, and even PU.1, can be used to separate fates within markedly
different major cell lineages. Also emerging from these reviews is that in the T-related
lineages at least, early development and later effector development make use of overlapping
but reshuffled sets of transcription factors. The ‘opportunistic’ use of transcription factors to
work in different pathways points to explanations for developmental roles not based on ‘the’
target genes of a given transcription factor but rather in the distinct set of sites to which that
transcription factor is recruited in a given developmental context, through interactions with
other factors.
These examples offer a gentle corrective to models of developmental choice that are based
on assuming a rigid dichotomy between two opposing ‘master regulators’. Comparing
different pathways discussed in this volume, we can see development from hematopoietic
stem cells making use of multiple combinations of transcription factors that need not always
mutually repress but which can work either cooperatively or antagonistically in different
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contexts. The reviews in this volume offer a glimpse of the astonishing richness of
functionally distinct cell types that can be generated as a result and the fluid and highly
regulated ways they can be used in the immune response.
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